HealthcareServices

AI In Cancer Diagnostics Market 2026–2030: Emerging Trends and Forecast Opportunities

February 19, 2026February 19, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the ai in cancer diagnostics market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the AI In Cancer Diagnostics Market from 2026 to 2030?

The ai in cancer diagnostics market size has experienced rapid expansion over recent years. This market is projected to expand from $0.79 billion in 2025 to reach $0.96 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 20.2%. Historical growth in this sector is linked to several factors, including limited AI integration in initial diagnostic procedures, a continued dependence on established imaging methods, the global rise in cancer cases, an escalating need for early detection options, and the proliferation of diagnostic facilities.

The ai in cancer diagnostics market is anticipated to experience significant expansion over the next few years. It is projected to achieve a value of $1.97 billion by 2030, growing at a compound annual growth rate (CAGR) of 19.9%. This increase during the forecast period is attributable to advancements in deep learning and machine learning algorithms, the proliferation of AI-powered imaging systems, the growing incorporation of predictive analytics in healthcare, increased investments in digital health technologies, and collaborative efforts between AI developers and medical institutions. Noteworthy trends during this time include the rising adoption of AI-based imaging and diagnostic tools, the integration of predictive analytics into cancer screening, the increasing application of AI for tumor identification and classification, the expansion of AI-driven monitoring and follow-up systems, and increased collaboration between hospitals and AI solution providers.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13567&type=smp

What Drivers Are Affecting Demand In The AI In Cancer Diagnostics Market?

The escalating occurrence of cancer is projected to fuel the expansion of artificial intelligence in the cancer diagnostics market. Cancer itself is characterized as a collection of diseases marked by uncontrolled cell proliferation, capable of invading or spreading to other bodily regions. The incorporation of AI into cancer care seeks to boost efficiency, precision, and tailored treatment alternatives, thereby bettering results for individuals with cancer. Illustratively, in May 2024, the National Cancer Institute, a US-based Government agency, reported that roughly 2 million new cancer cases are anticipated to be diagnosed in the U.S. in 2024, alongside projections of more than 611,000 deaths. Looking ahead, by 2040, new cancer cases are forecasted to climb to 29.9 million globally, with cancer-related fatalities expected to reach 15.3 million. Consequently, the rising incidence of cancer acts as a primary catalyst for the growth of artificial intelligence in the cancer diagnostics market.

Which Segments Are Gaining Traction In The AI In Cancer Diagnostics Market?

The ai in cancer diagnostics market covered in this report is segmented –

1) By Component: Software Solutions, Hardware, Services

2) By Cancer Type: Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types

3) By Application: Screening And Diagnosis, Tumor Identification, Monitoring

4) By End User: Hospitals, Diagnostic Centers, Medical Research Institutes

Subsegments:

1) By Software Solutions: Machine Learning Software, Deep Learning Software, Image Analysis Software

2) By Hardware: AI-Powered Imaging Systems, Diagnostic Devices

3) By Services: AI Integration Services, Consulting And Training Services, Support And Maintenance Services

Which Market Trends Are Opening Growth Opportunities In The AI In Cancer Diagnostics Market?

Major companies in the AI in cancer diagnostics market are experiencing substantial growth, primarily driven by progress in AI-driven digital pathology solutions for cancer detection. AI-powered digital pathology solutions for cancer diagnosis refer to the use of artificial intelligence algorithms to identify cancer and other diagnostic features in various tissue types, which in turn provides accurate and timely cancer diagnosis, supports case prioritization, and ensures reproducible diagnoses. As an example, in November 2023, Dedalus and Ibex Medical Analytics, a Europe-based health software company, unveiled an integrated End-to-End AI-powered digital pathology solution for cancer diagnosis across Europe. This particular solution aims to enhance accuracy, deliver AI-powered decision support tools, simplify reporting, improve laboratory efficiency, and boost diagnostic confidence.

Who Are The Core Companies Influencing Trends In The AI In Cancer Diagnostics Market?

Major companies operating in the ai in cancer diagnostics market are Microsoft Corporation, IBM Corporation, Verily Life Sciences LLC, Tempus Labs Inc, Guardant Health Inc, Lunit Inc, Paige AI Inc, Viz.ai Inc, Enlitic Inc, Ibex Medical Analytics Ltd, Kheiron Medical Technologies Limited, CureMetrix Inc, CancerIQ Inc, MultiplAI Health Inc, Freenome Holdings Inc, SkinVision B V, Owkin Inc, Imagen Technologies Inc, Cyrcadia Health Inc, Oncora Medical Inc, Xilis Inc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

Which Regions Are Projected To Dominate The AI In Cancer Diagnostics Market In The Coming Years?

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2025. The regions covered in the ai in cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized AI In Cancer Diagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13567&type=smp

Browse Through More Reports Similar to the Global AI In Cancer Diagnostics Market 2026, By The Business Research Company

Artificial Intelligence In The Diagnostic Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-the-diagnostic-global-market-report

Artificial Intelligence In Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cancer-diagnostics-global-market-report

Ai In Medical Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795